Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2012, Vol. 17 ›› Issue (11): 1268-1271.

Previous Articles     Next Articles

Clinical study of combination treatment with clofazimine and others for patients with multi-drug-resistant tuberculosis

WANG Huai-chong1, XU Ying-ying1, ZHANG Xiang-cai1, ZHANG Li-bin2, CAO Jia-wei1, WANG Cui-lian1   

  1. 1Department of Pharmacy, Integrated Chinese and Western Medicine Hospital of Zhejiang Province, Hangzhou 310003, Zhejiang, China;
    2Department of Pharmacy, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai 200433, China
  • Received:2012-02-23 Revised:2012-10-24 Published:2012-12-04

Abstract: AIM: To investigate the efficacy of combination treatment with clofazimine and other antituberculosis drugs for patients with multi-drug-resistant tuberculosis. METHODS: 72 cases with multi-drug-resistant tuberculosis were randomly divided into experimental group (n=32) and control group (n=40). The treatment effect was observed at the 6th month and 18th month after treatment. RESULTS: 6 months later, the sputum negtive conversion rate in smear and in culture were 81.3% and 84.4% respectively and the rate in X-rays focus absorption was 37.5% in experimental group, which were significantly higher than those in control group. CONCLUSION: Combination treatment with clofazimine and others for patients with multi-drug-resistant tuberculosis can improve the curative effect and shorten course of treatment especially in the stage strengthened.

Key words: Clofazimine, Multi-drug-resistant Tuberculosis, Efficacy, Antituberculosis drugs

CLC Number: